Pyrazolyl–Pyridine Ruthenium Complexes: A New Metallic Line of Defense Against Acinetobacter baumannii
ChemBioChem · 14.05.2026 · 27 (9)
DOI: 10.1002/cbic.70371 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 10.05.2026. Verfasst von M Cassiem Joseph und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Ruthenium, Anti-Bacterial Agents, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Wellcome Trust, NRF.
Abstract (Originalsprache)
The emergence of antimicrobial resistance (AMR), especially among ESKAPE infections, highlights the pressing necessity for novel chemical frameworks with atypical modes of action. Transition‐metal complexes have emerged as attractive possibilities owing to their varied geometries, redox activity, and capacity to interact with biological sites inaccessible to traditional chemical antibiotics. This study presents the antibacterial and antifungal assessment of a series of Ru(II) pyrazolyl–pyridine half‐sandwich complexes ( C1 – C6 ), thereby broadening the chemical scope of metalloantibiotics previously investigated inside pyridyl–1,2,3‐triazolyl frameworks. The compounds were synthesized with good yields and structurally validated by single‐crystal X‐ray diffraction, demonstrating piano‐stool topologies with unique ligand‐dependent anion orientations. Extensive biological screening via the Community for Open Antimicrobial Drug Discovery (CO‐ADD) platform revealed selective efficacy of complexes C1 – C3 against Acinetobacter baumannii, a significant multidrug‐resistant pathogen. Cytotoxicity and hemolysis assessments revealed advantageous therapeutic ranges for the most potent combinations. Biophysical investigations, encompassing DNA‐binding fluorescence displacement, linear dichroism, and in silico molecular docking and dynamics, elucidated that the lead drug interacts with bacterial DNA via partial intercalation and groove contacts. Collectively, our findings establish Ru(II) pyrazolyl–pyridine complexes as prospective candidates for the advancement of next‐generation metalloantibiotics and underscore the significance of coordination‐chemistry‐driven approaches in addressing AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Chemistry and Polymer Science, University of Stellenbosch, Stellenbosch, South Africa.
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Australia.
ORCID-Profile: M Cassiem Joseph, Sheldon Sookai, Andrew J Swarts
Förderung
- National Research Foundation
- Wellcome Trust
- NRF
- WT
Zitieren
APA
Joseph, M. C., Sookai, S., Nowakowska, M., Mphephu, R., Kavanagh, A. M., Zuegg, J., Blaskovich, M. A. T., & Swarts, A. J. (2026). Pyrazolyl–Pyridine Ruthenium Complexes: A New Metallic Line of Defense Against Acinetobacter baumannii. ChemBioChem, 27(9). https://doi.org/10.1002/cbic.70371
Vancouver
Joseph MC, Sookai S, Nowakowska M, Mphephu R, Kavanagh AM, Zuegg J, et al. Pyrazolyl–Pyridine Ruthenium Complexes: A New Metallic Line of Defense Against Acinetobacter baumannii. ChemBioChem. 2026;27(9). doi:10.1002/cbic.70371
BibTeX
@article{Joseph2026,
author = {Joseph, M Cassiem and Sookai, Sheldon and Nowakowska, Monika and Mphephu, Rotondwa and Kavanagh, Angela M and Zuegg, Johannes and Blaskovich, Mark A T and Swarts, Andrew J},
title = {Pyrazolyl–Pyridine Ruthenium Complexes: A New Metallic Line of Defense Against Acinetobacter baumannii},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {9},
doi = {10.1002/cbic.70371}
}
EUVIMED